Related Experiment Video
Updated: May 27, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
[Pneumonia caused by Fusobacterium necrophorum: is Lemierre syndrome still current?]
Dolunay Gülmez1, Sehnaz Alp, Arzu Topeli İskit
1Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey. dolunay@hacettepe.edu.tr
Abstract:
Fusobacterium necrophorum is a non-spore-forming gram-negative anaerobic bacillus that may be the causative agent of localized or severe systemic infections. Systemic infections due to F.necrophorum are known as Lemierre's syndrome, postanginal sepsis or necrobacillosis. The most common clinical course of severe infections in humans is a progressive illness from tonsillitis to septicemia in previously healthy young adults. A septic thrombophlebitis arising from the tonsillar veins and extending into the internal jugular vein leads to septicemia and septic emboli contributing to the development of necrotic abscesses especially in lungs and other tissues such as liver, bone and joints. In this case report, a previously healthy man with pneumonia and empyema due to F.necrophorum has been presented. A 22 year-old man suffering from sore throat for seven days was admitted to emergency department with ongoing fever and dysphagia for three days. On admission he was already taking amoxicillin-clavulanic acid and his complaints were relieved with continuation of therapy to a total of 10 days. However, five days after the cessation of treatment he developed productive cough, fever and generalized myalgia. On physical examination, there were crackles on right lower lung, and chest X-ray revealed pulmonary consolidation on the right middle lobe. Levofloxacin therapy was started based on the diagnosis of pneumonia. While polymorphonuclear leucocytes and intracellular gram-negative bacilli were seen in Gram stained sputum smear, sputum culture was reported as normal flora. Although the patient's status had started to improve with treatment, his condition deteriorated with development of fever and dyspnea. Chest X-ray revealed consolidation, pulmonary infiltrates, pleural effusion and air-fluid level on the right. Meropenem, clarithromycin and linezolid were initiated and a chest tube was inserted with the preliminary diagnosis of necrotizing pneumonia, empyema and type-1 respiratory failure. While there was no growth on bronchoalveolar lavage fluid culture, thoracentesis material inoculated into thioglycolate broth revealed turbidity. Further inoculation onto Schaedler agar which was incubated under anaerobic conditions, yielded growth of catalase negative, indol positive, gram-negative anaerobic bacilli identified as F.necrophorum by BBL Crystal system (Becton Dickinson, USA). The detailed history of the patient revealed that fish bone had stuck in his throat a week ago. Clarithromycin and linezolid were discontinued and he was recovered within six weeks of meropenem treatment. F.necrophorum infection should be considered in the differential diagnosis of persistent head and neck infections with rapidly progressive metastatic necrotic lesions especially in healthy young adults and clindamycin or metranidazol should be added to the treatment protocols.
Insights
Fusobacterium necrophorum can cause severe pneumonia and empyema in young adults, often following a sore throat. Prompt diagnosis and appropriate antibiotic treatment, including anaerobic coverage, are crucial for recovery.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Fusobacterium necrophorum is a gram-negative anaerobic bacillus implicated in severe systemic infections, including Lemierre's syndrome.
- These infections typically progress from head and neck infections to septicemia with metastatic abscess formation, particularly in the lungs.
Observation:
- A previously healthy 22-year-old male presented with pneumonia and empyema.
- Initial symptoms included sore throat, fever, and dysphagia, followed by worsening respiratory distress after initial antibiotic treatment.
Findings:
- Gram stain of sputum revealed gram-negative bacilli, but initial cultures were inconclusive.
- Thoracentesis and anaerobic culture ultimately identified Fusobacterium necrophorum as the causative agent.
- The patient recovered after treatment with meropenem, with adjunctive anaerobic coverage suggested.
Implications:
- Fusobacterium necrophorum should be considered in the differential diagnosis of severe, rapidly progressing respiratory infections in young adults.
- Treatment protocols for such infections should include antibiotics effective against anaerobic bacteria, such as clindamycin or metronidazole.
- Early recognition and targeted therapy are vital to prevent severe outcomes.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Atypical Pneumonia
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Phylum Spirochaetes